n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Palmoplantaris Pustulosis

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with Palmoplantaris Pustulosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Warren, RB; Yiu, ZZ	1
Benea, V; Bristol, DR; Cohen, S; Cosgarea, MR; Cristodor, P; David, M; Demerdjieva, ZV; Farbstein, M; Fishman, P; Gheorghe, N; Giurcaneanu, C; Gospodinov, DK; Harpaz, Z; Hitova, MC; Horia, B; Hristakieva, E; Kadurina, MI; Mateev, GS; Michael, Z; Morariu, HS; Nica, C; Patel, RV; Purcaru, AI; Ramon, M; Rotaru, M; Rusinova, MV; Silverman, MH; Simionescu, O; Solovastru, LG; Tsingov, II; Yankova, RK	1
Akerman, L; David, M; Fishman, P; Gospodinov, D; Kadurina, M; Kouzeva, V; Pavlotsky, F; Ramon, M; Silverman, MH; Yankova, R; Ziv, M	1

Reviews

1 review(s) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Palmoplantaris Pustulosis

Article	Year
Novel Oral Therapies for Psoriasis and Psoriatic Arthritis. American journal of clinical dermatology, 2016, Volume: 17, Issue:3 Topics: Adamantane; Adenosine; Adenosine A3 Receptor Antagonists; Administration, Oral; Arthritis, Psoriatic; Azetidines; Biological Factors; Biological Therapy; Clinical Trials as Topic; Humans; Isonicotinic Acids; Janus Kinases; Niacinamide; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; rho-Associated Kinases; Sulfonamides; Thalidomide; Thiazoles	2016

Article

Year

Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.

American journal of clinical dermatology, 2016, Volume: 17, Issue:3

Topics: Adamantane; Adenosine; Adenosine A3 Receptor Antagonists; Administration, Oral; Arthritis, Psoriatic; Azetidines; Biological Factors; Biological Therapy; Clinical Trials as Topic; Humans; Isonicotinic Acids; Janus Kinases; Niacinamide; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; rho-Associated Kinases; Sulfonamides; Thalidomide; Thiazoles

2016

Trials

2 trial(s) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Palmoplantaris Pustulosis

Article	Year
Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled Trial. Journal of drugs in dermatology : JDD, 2016, 08-01, Volume: 15, Issue:8 Topics: Adenosine; Administration, Oral; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Psoriasis; Statistics as Topic; Treatment Outcome; Young Adult	2016
Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial. Journal of the European Academy of Dermatology and Venereology : JEADV, 2012, Volume: 26, Issue:3 Topics: Adenosine; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Psoriasis; Treatment Outcome	2012